Here are relevant reports on : short-term-disability-insurance-market
-
Automobile Insurance Market - Industry Trends & Forecast to 2020
Automobile insurance is insurance purchased for cars, trucks, motorcycles and other road vehicles to provide financial protection against physical damage resulting from traffic collisions and theft of the vehicle. As the number of road accidents is high in most countries across the globe, the automobile insurance market has a lot of scope for growth. Vehicle insurance is compulsory in almost all legislations which would lead to sustainable growth of the automobile insurance market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Noise Monitoring Market by Sampling Method (Short-term, Long-term, & Permanent Monitoring), precision Type (Class 1 & Class 2), Connectivity (Wi-Fi, Cellular, Ethernet, & USB), Solution (Hardware, Software, & Service), Application, and Geography - Global Growth Driver and Industry Forecast to 2035
The noise monitoring market is expected to reach USD 806.5 Million by 2023 from USD 610.2 Million in 2016, at a CAGR of 4.1% between 2017 and 2023. The report also profiles the most promising players in this market. The key players in this market are Svantek (Poland), RION Co. Ltd. (Japan), Bruel & Kjaer (Denmark), Cirrus Research Plc (UK), Extech Instruments (US), Pulsar Instruments (UK), 3M (US), Nti-Audio (Liechtenstein), Castle Group Ltd. (UK), SKF Group (Sweden), Kimo Instrument (Japan), B&K Precision Corporation (US), HT Instruments (Germany), 01dB (ACOEM Group) (France), SINUS Messtechnik GmbH (Germany), CESVA INSTRUMENTS SLU (Spain), Testo SE & Co. KGaA (Germany), and Casella Inc. (US).
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region - Global Forecast to 2025
The global clinical workflow solutions market growth is primed to transition from USD 9.1 billion in 2020 to USD 18.1 billion by 2025, showcasing a strong CAGR of 14.8%. Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities) and Region - Global Forecasts to 2027
The global infection surveillance solutions market growth is primed to transition from $577 million in 2022 to $1,100 billion by 2027, showcasing a strong CAGR of 13.8%. The market growth is primarily driven by the rising number of hospital-acquired infections (HAIs) and new Medicare policies that include non-payment for hospital-acquired conditions.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) & Geography
The automated blood tube labeler market is projected to grow at a CAGR of 6.8% during the forecast period. The market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Long Term Evolution (LTE) Market (2010-2015) By Infrastructure (E-Utran, E Node B, EPC), End-User Devices (Smartphones, USB Modems, Card Modules, Netbooks) & Services
The need for mobile broadband is growing everyday as digital lifestyle continues to evolve with the line between cell phones, mobile handheld devices, PCs and laptops getting blurred. Users continue to show increasing interest for real time applications that include video-conferencing, publishing and social networking. Subscriber’s interest in accessing high bandwidth applications such as YouTube from their mobile phones are further taxing the already stressed networks of mobile service providers. To meet this increasing demand for bandwidth, operators are migrating to LTE, which provides them with an opportunity to introduce new services such as data download, accessing internet from mobiles and ultimately helping them to improve their bottom-line.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. The growth of the Europe human microbiome market is driven by increased awareness of personalized health, the adoption of microbiome-based therapies, and advancements in sequencing technologies and bioinformatics.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
